(S)-emopamil, a novel calcium channel blocker and serotonin s2 antagonist, markedly reduces infarct size following middle cerebral artery occlusion in the rat

Neurology

Volumn 38, Issue 11, 1988, Pages 1667-1673

  Nakayama, Hitoshi ^a   Ginsberg, Myron D ^a   Dietrich, W Dalton ^a  

^a UNIVERSITY OF MIAMI MILLER SCHOOL OF MEDICINE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

CALCIUM CHANNEL BLOCKING AGENT; EMOPAMIL; SEROTONIN 2 ANTAGONIST;

ANIMAL EXPERIMENT; ANIMAL MODEL; BRAIN INFARCTION; HISTOLOGY; INTRAPERITONEAL DRUG ADMINISTRATION; MALE; MAMMAL; NONHUMAN; PRIORITY JOURNAL; RAT;

ANIMAL; CALCIUM CHANNEL BLOCKERS; CEREBRAL ARTERIES; CEREBRAL INFARCTION; MALE; RATS; RATS, INBRED STRAINS; SEROTONIN ANTAGONISTS; SUPPORT, NON-U.S. GOV'T; SUPPORT, U.S. GOV'T, P.H.S.; VERAPAMIL;

EID: 0023732415     PISSN: 00283878     EISSN: 1526632X     Source Type: Journal    
DOI: 10.1212/wnl.38.11.1667     Document Type: Article

References (42)

1. l. Greenberg DA., Calcium channels and calcium channel antagonists. Ann Neurol 1987;21:317-330.
2. Harris RJ, Branston NM, Symon L, Bayhan M, Watson A, The effects of a calcium antagonist, nimodipine, upon physiological responses of the cerebral vasculature and its possible influence upon focal cerebral ischaemia. Stroke 1982;13:759-766.
3. Siesjö BL. Cell damage in the brain: a speculative synthesis. J Cereb Blood Flow Metab 1981;1:155-185.
4. Raichle ME. The pathophysiology of brain ischemia. Ann Neurol 1983;13:2-10.
5. Tamura A, Graham DI, McCulloch J, Teasdale GM. Focal cerebral ischaemia in the rat. 1. Description of technique and early neuropathological consequences following middle cerebral artery occlusion. J Cereb Blood Flow Metab 1981;1:53-60.
6. Gotoh O, Mohamed AA, McCulloch J, Graham DI, Harper AM, Teasdale GM. Nimodipine and the haemodynamic and histo-pathological consequences of middle cerebral artery occlusion in the rat. J Cereb Blood Flow Metab 1986;6:321-331.
7. Nakayama H, Dietrich WD, Watson BD, Busto R, Ginsberg MD. Photothrombotic occlusion of rat middle cerebral artery: histo-pathological and hemodynamic sequelae of acute recanalization. J Cereb Blood Flow Metab 1988;8:357-366.
8. Kirk RE. Experimental design: procedures for the behavioral sciences, 2nd ed. Monterey, CA: Brooks Cole, 1982.
9. König J-FR, Klippel RA. The rat brain. A stereotaxic atlas of the forebrain and lower parts of the brain stem. Huntington, NY: Robert F. Krieger, 1963.
10. Mohamed AA, Gotoh O, Graham DI, et al. Effect of pretreatment with the calcium antagonist nimodipine on local cerebral blood flow and histopathology after middle cerebral artery occlusion. Ann Neurol 1985;18:705-711.
11. Germano IM, Bartkowski HM, Cassel ME, Pitts LH. The therapeutic value of nimodipine in experimental focal cerebral ischemia. J Neurosurg 1987;67:81-87.
12. Kobayashi S, Obana W, Andrews BT, Nishimura MC, Pitts LH. Lack of effect of nimodipine in experimental regional cerebral ischemia. Stroke 1988;19:147.
13. Gelmers HF, Gorter K, deWeerdt CJ, Wiezer HJA. A controlled study of nimodipine in acute ischemic stroke. N Engl J Med 1988;318:203-207.
14. Garcia JH. Experimental ischemic stroke: a review. Stroke 1984;15:5-14.
15. Weinstein PR, Anderson GG, Telles DA. Neurological deficit and cerebral infarction after temporary middle cerebral artery occlusion in unanesthetized cats. Stroke 1986;17:318-331.
16. Schuier FJ, Hossmann K-A. Experimental brain infarcts in cats. II. Ischemic brain edema. Stroke 1980;11:593-601.
17. Rehncrona S, Rosen I, Siesjö BK, Brain lactic acidosis and ischemic cell damage. I. Biochemistry and neurophysiology. J Cereb Blood Flow Metab 1981;1:297-311.
18. Steen PA, Newberg LA, Milde JH, Michenfelder JD. Nimodipine improves cerebral blood flow and neurologic recovery after complete cerebral ischemia in the dog. J Cereb Blood Flow Metab 1983;3:38-43.
19. Steen PA, Newberg LA, Milde JH, Michenfelder JD. Cerebral blood flow and neurologic outcome when nimodipine is given after complete cerebral ischemia in the dog. J Cereb Blood Flow Metab 1984;4:82-87.
20. Milde LN, Milde JH, Michenfelder JD. Delayed treatment with nimodipine improves cerebral blood flow after complete cerebral ischemia in the dog. J Cereb Blood Flow Metab 1986;6:332-337.
21. Steen PA, Gisvold SE, Milde JH, et al. Nimodipine improves outcome when given after complete cerebral ischemia in primates. Anesthesiology 1985;62:406-414.
22. Alps BJ, Hass WK. The potential benefit of nicardipine in a rat model of transient forebrain ischemia. Neurology 1987;37:809-814.
23. Vibulsresth S, Dietrich WD, Busto R, Ginsberg MD. Failure of nimodipine to prevent ischemic neuronal damage in rats. Stroke 1987;18:210-216.
24. Berger JR, Busto R, Ginsberg MD. Verapamil: failure of metabolic amelioration following global forebrain ischemia in the rat. Stroke 1984;15:1029-1032.
25. Fleischer JE, Lanier WL, Milde JH, Michenfelder JD. Effect of lidoflazine on cerebral blood flow and neurologic outcome when administered after complete cerebral ischemia in dogs. Anesthesiology 1987;66:304-311.
26. Deshpande JK, Wieloch T. Flunarizine, a calcium entry blocker, ameliorates ischemic brain damage in the rat. Anesthesiology 1986;64:215-224.
27. Newberg LA, Steen PA, Milde JH, Michenfelder JD. Failure of flunarizine to improve cerebral blood flow or neurologic recovery in a canine model of complete cerebral ischemia. Stroke 1984;15:666-671.
28. Szabo L, Hofmann HP, Raschack M, Unger L. S-Emopamil: a new calcium antagonist of the verapamil group with high cerebral availability and antiischemic properties. Soc Neurosci Abstr 1988 (in press).
29. Bielenberg GW, Beck T, Sauer D, Bumiol M, Krieglstein J. Effects of cerebroprotective agents on cerebral blood flow and on postischemic energy metabolism in the rat brain. J Cereb Blood Flow Metab 1987;7:480-488.
30. Bielenberg GW, Haubruck H, Krieglstein J. Effects of calcium entry blocker emopamil on postischemic energy metabolism of the isolated perfused rat brain. J Cereb Blood Flow Metab 1987;7:489-496.
31. O’Hearn E, Molliver ME. Organization of raphe-cortical projections in the rat: a quantitative retrograde study. Brain Res Bull 1984;13:709-726.
32. Reinhard JF, Liebmann JE, Schlosberg AJ, Moskowitz MA. Serotonin neurons project to small blood vessels in the brain. Science 1979;206:85-87.
33. Mrsulja BB, Mrsulja BJ, Spatz M, Klatzo I. Brain serotonin after experimental vascular occlusion. Neurology 1976;26:785-787.
34. Welch K.M.A., Meyer JS, Teraura T, Hashi K, Shinmaru S. Ischemic anoxia and cerebral serotonin levels. J Neurol Sci 1972;16:85-92.
35. Auer LM, Leber K, Sayama I. Effect of serotonin and its antagonist ketanserin on pial vessels. J Cereb Blood Flow Metab 1985;5:517-522.
36. Bederson JB, Pitts LH, Tsuji M, Nishimura MC, Davis RL, Bartkowski H. Rat middle cerebral artery occlusion: evaluation of the model and development of a neurologic examination. Stroke 1986;17:472-476.
37. Yamori Y, Horie R, Handa H, Sato M, Fukase M. Pathogenetic similarity of strokes in stroke-prone spontaneously hypertensive rats and humans. Stroke 1976;7:46-53.
38. Tamura A, Graham DI, McCulloch J, Teasdale GM. Focal cerebral ischemia in the rat: 2. Regional cerebral blood flow determined by (14C)iodoantipyrine autoradiography following middle cerebral artery occlusion. J Cereb Blood Flow Metab 1981;1:61-69.
39. Shigeno T, Teasdale GM, McCulloch J, Graham DI. Recirculation model following MCA occlusion in rats. J Neurosurg 1985;63:272-277.
40. Tyson GW, Teasdale GM, Graham DI, McCulloch J. Focal cerebral ischemia in the rat: topography of hemodynamic and histo-pathological changes. Ann Neurol 1984;15:559-567.
41. Hakim AM. Cerebral acidosis in focal ischemia: II. Nimodipine and verapamil normalize cerebral pH following middle cerebral artery occlusion in the rat. J Cereb Blood Flow Metab 1986;6:676-683.
42. Zervas NT, Kuwayama A, Rosoff CB, Salzman EW. Cerebral arterial spasm. Modification by inhibition of platelet function. Arch Neurol 1973;28:400-404.